BioCentury
ARTICLE | Company News

ES Cell International Pte Ltd., Stanford University deal

February 3, 2003 8:00 AM UTC

ES Cell received a license to the university's technology for transforming embryonic stem cells into a renewable source of insulin producing cells. ES Cell plans to develop the technology into a cell ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article